Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|June 28, 2018
Immune Targeting of Tetraspanins Involved in Cell Invasion and MetastasisFelipe Vences-Catalán, Shoshana Levy
IUBMB Life|September 9, 2011
CD38 through the life of a murine B lymphocyteFelipe Vences-Catalán, Leopoldo Santos-Argumedo
Biochemical and Biophysical Research Communications|June 27, 2015
Role of an arginine-lysine rich motif in maturation and trafficking of CD19Felipe Vences-Catalán, Chiung-Chi Kuo, Shoshana Levy
Immunology|May 9, 2012
The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytesFelipe Vences-Catalán, Ranjani Rajapaksa, Shoshana Levy, et al.
Biochemical Society Transactions|April 15, 2017
CD81 as a tumor targetFelipe Vences-Catalán, Caroline Duault, Chiung-Chi Kuo, et al.
Cancer Research|September 3, 2015
Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cellsFelipe Vences-Catalán, Ranjani Rajapaksa, Minu K Srivastava, et al.
Oncoimmunology|July 29, 2016
Tetraspanin CD81, a modulator of immune suppression in cancer and metastasisFelipe Vences-Catalán, Ranjani Rajapaksa, Minu K Srivastava, et al.
The Journal of Experimental Medicine|May 25, 2019
CD81 is a novel immunotherapeutic target for B cell lymphomaFelipe Vences-Catalán, Chiung-Chi Kuo, Ranjani Rajapaksa, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2017
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regressionJonathan P O Hebb, Adriane R Mosley, Felipe Vences-Catalán, et al.
Infection and Immunity|July 25, 2018
EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin MicrodomainsRachana Pattani Ramachandran, Felipe Vences-Catalán, Dan Wiseman, et al.
Pageof 2